Objective
"Cancer is a major socio-economic problem in EU, with approximately 2.5 million cases diagnosed and 1.2 million deaths every year, and an annual estimated cost of 15 billion € for cancer therapy. Understanding the molecular mechanisms underlying cancer progression have revolutionized the field of targeted therapies, generating a growing number of inhibitors approved for use in the clinic. In particular, drugs targeting receptor tyrosine kinases (RTKs) have been successful. Although several of these therapies showed initial benefits, a recurring problem in cancer management is development of secondary mutations of the targeted proteins, causing drug resistance. To counteract this, there is an urgent need to identify the next generation of drug targets required to create the second line therapies that are critically needed. The specific aim of this proposal is to elucidate the molecular networks that modify RTK signalling output during tumour progression to metastatic disease, with the aim of identifying network nodes that can subsequently be targeted for drug development.
The goal of this proposal is to investigate the molecular mechanisms whereby RTK signalling output is modified, and how they are altered during cancer progression to metastatic disease. In vivo, tumour cells are simultaneously exposed to signals initiated by a variety of oncogenes, cytokine receptors and adhesion molecules, and it is the integrated signals that determine the cellular phenotype. Realizing that cancer is a disease of networks, this proposal investigates signal integration at the level of regulating RTK internalization and trafficking. Specifically, the proposed research will significantly expand the understanding of the intersection between two interlinked networks that regulate RTK signalling, i.e. PTPs and endocytic trafficking. The ultimate aim of this line of research is to identify novel drug targets that can subsequently be exploited by the European pharmaceutical industry."
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance
- natural sciences biological sciences genetics mutation
- medical and health sciences clinical medicine oncology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2012-CIG
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MC-CIG - Support for training and career development of researcher (CIG)
Coordinator
B15 2TT Birmingham
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.